Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Tag: remdesivir

Time for new pharmaceutical-innovation models

Ellen 't Hoen - February 11, 2020

Recent Posts

Time for new pharmaceutical-innovation models
Wrapping up 2019 – Noteworthy Medicines Law and Policy Events
Socially Responsible Licensing of Medical Technologies
Uganda tells ARIPO: No more patents for pharmaceuticals

Posts by Subject

access to knowledge Access to Medicines ARIPO Cancer CDCA competition law Compulsory licensing compulsory licensing for export cystic fibrosis Data exclusivity Delinkage DNDi dolutegravir European Union evergreening Fair Pricing France Gilead Hepatitis C HIV IFPMA LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands orkambi Orphan Drugs Patent patent opposition Patents PrEP R&D Sofosbuvir SPC Supplementary Protection Certificates The Netherlands transparency TRIPS flexibilities Truvada UK United Nations High Level Panel WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: info@medicineslawandpolicy.net.

This work is licensed under Creative Commons.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok